Clinical Trial Update: A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause [Phase 3]

View source ↗

Summary

A Phase 3 trial in Asia completed to assess whether fezolinetant reduces moderate-to-severe hot flashes in menopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Fezolinetant (fezolinetant)

Snippet

Sponsor: Astellas Pharma China, Inc. | Conditions: Hot Flashes | Phase 3 | Status: COMPLETED